Science Links Japan | Basic knowledge and clinical aspects of ketamine. Intravenous microdrip infusion of ketamine for neuropathic pain and intractable terminal cancer pain.

Basic knowledge and clinical aspects of ketamine. Intravenous microdrip infusion of ketamine for neuropathic pain and intractable terminal cancer pain.

Accession number;03A0313430

Title;Basic knowledge and clinical aspects of ketamine. Intravenous microdrip infusion of ketamine for neuropathic pain and intractable terminal cancer pain.

Author; KATO JITSU (Nihon Univ., Sch. of Med.)

Journal Title;Pain Clinic

Journal Code:G0739B

ISSN:0388-4171

VOL.24;NO.4;PAGE.493-499(2003)

Figure&Table&Reference;REF.25

Pub. Country;Japan

Language;Japanese

Abstract;Ketamine is an intravenous anesthetic with an anesthetic action and a strong analgesic action; it was used as a general anesthetic in the operation.The NMDA(N-methyl-D-aspartic acid) receptor and the ion channel are involved in its mode of action.In the meantime, it is recognized that ketamine is useful as a therapeutic drug for neurogenic pain and cancerous pain.None of the administration pathway, the dose, and the administration period of ketamine has been established; various methods are being used.The present state of the ketamine continuous infusion therapy was introduced.The following were explained: Indications, actual methods, explanations to patients, cautions, side effects, and treatment outcomes, regarding each of them.

Related Articles;